Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Novel Targeted and High‐Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease
Han Yang, Weihang Mu, Daohe Wei, et al.
Advanced Science (2020) Vol. 7, Iss. 19
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Multifunctional nanoparticle-mediated combining therapy for human diseases
Xiaotong Li, Xiuju Peng, Makhloufi Zoulikha, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 130
Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management
Baljinder Singh, Candace M. Day, Sadikalmahdi Abdella, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 402-424
Open Access | Times Cited: 53
Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases
Qianqian Huang, Yongke Chen, Weiwei Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 519-534
Closed Access | Times Cited: 44
Pathological BBB Crossing Melanin-Like Nanoparticles as Metal-Ion Chelators and Neuroinflammation Regulators against Alzheimer’s Disease
Qianqian Huang, Chaoqing Jiang, Xue Xia, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 42
Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Yue Zhang, Han Yang, Daohe Wei, et al.
Exploration (2021) Vol. 1, Iss. 3
Open Access | Times Cited: 98
Human Serum Albumin Based Nanodrug Delivery Systems: Recent Advances and Future Perspective
Changyong Li, Da-Gui Zhang, Yu-Jing Pan, et al.
Polymers (2023) Vol. 15, Iss. 16, pp. 3354-3354
Open Access | Times Cited: 32
Imine-Linked Covalent Organic Framework Modulates Oxidative Stress in Alzheimer’s Disease
Qingfan Ren, Huiting Chen, Yuying Chen, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 4, pp. 4947-4958
Closed Access | Times Cited: 24
Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery
Tahereh Jamshidnejad-Tosaramandani, Soheila Kashanian, Isaac Karimi, et al.
Polymers (2024) Vol. 16, Iss. 4, pp. 510-510
Open Access | Times Cited: 13
Revolutionizing Alzheimer's treatment: Harnessing human serum albumin for targeted drug delivery and therapy advancements
D. Shastri, Vinit Raj, Sang‐Kil Lee
Ageing Research Reviews (2024) Vol. 99, pp. 102379-102379
Closed Access | Times Cited: 10
Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases
Adriana Jiménez, Enrique Estudillo, Mara A. Guzmán‐Ruiz, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 281-281
Open Access | Times Cited: 1
Binding to Amyloid‐β Protein by Photothermal Blood‐Brain Barrier‐Penetrating Nanoparticles for Inhibition and Disaggregation of Fibrillation
Hao Geng, Yu‐Chen Pan, Ran Zhang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 41
Closed Access | Times Cited: 54
Biomarker‐Responsive Nanosystems for Chronic Disease Theranostics
Qinrui Fu, Leilei Yu, Yin Wang, et al.
Advanced Functional Materials (2022) Vol. 33, Iss. 2
Closed Access | Times Cited: 32
Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice
Lingxiao Zhang, Shengjie Hou, Fatemeh Movahedi, et al.
Nano Today (2023) Vol. 49, pp. 101788-101788
Closed Access | Times Cited: 21
Emerging nanotechnology for Alzheimer's disease: From detection to treatment
Nan Song, Si Sun, Ke Chen, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 392-417
Closed Access | Times Cited: 21
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17
Intranasal liposomes co-delivery of Aβ-targeted KLVFF and ROS-responsive ceria for synergistic therapy of Alzheimer’s disease
Qiujie Shan, Yue Zhi, Yi Chen, et al.
Chemical Engineering Journal (2024) Vol. 494, pp. 153210-153210
Open Access | Times Cited: 6
Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients
Mohamed Abbas
Polymers (2021) Vol. 13, Iss. 7, pp. 1051-1051
Open Access | Times Cited: 38
Composite of gold nanoclusters and basified human serum albumin significantly boosts the inhibition of Alzheimer's β-amyloid by photo-oxygenation
Wei Liu, Hui Zhang, Xiaoyan Dong, et al.
Acta Biomaterialia (2022) Vol. 144, pp. 157-167
Closed Access | Times Cited: 27
Brain Glucose Activated MRI Contrast Agent for Early Diagnosis of Alzheimer’s Disease
Jiamin Liu, Chuyao Chen, Huiting Chen, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 46, pp. 16213-16221
Closed Access | Times Cited: 23
Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
Anna Atlante, Giuseppina Amadoro, Valentina Latina, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6742-6742
Open Access | Times Cited: 23
Plant‐derived peptides for the improvement of Alzheimer's disease: Production, functions, and mechanisms
Like Lin, Cong Li, Tingting Li, et al.
Food Frontiers (2023) Vol. 4, Iss. 2, pp. 677-699
Open Access | Times Cited: 14
Recent progress of nanomedicine in the treatment of Alzheimer’s disease
Liqiang Hu, Yiran Tao, Yanjiao Jiang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Key Transdermal Patch Using Cannabidiol-Loaded Nanocarriers with Better Pharmacokinetics in vivo
Po-Cheng Chu, Man-Hua Liao, Mao-Gu Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4321-4337
Open Access | Times Cited: 5
Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy
Yilong Xi, Yun Chen, Yi Jin, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 38-61
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top